BELKIN Laser Ltd. careers

BELKIN Laser is developing a unique one-second laser treatment for glaucoma, aimed at revolutionizing access to glaucoma care by offering a very simple laser therapy that can be applied by every ophthalmologist as a first-line therapy option to every glaucoma patient.
The procedure is non-invasive, painless, non-contact, instantaneous, automated, activated with a single press of a button, thus requires negligible learning curve.
Our one-second, once-a-year glaucoma laser treatment is a real alternative to daily eye drops regimen.
64 million people suffer from glaucoma. Over 200,000 ophthalmologists worldwide will have the opportunity to offer their patients BELKIN's treatment.
BELKIN also provides an exclusive solution for glaucoma in asian populations.